Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L lens solution troubles

This article was originally published in The Gray Sheet

Executive Summary

Preliminary 2006 year-end results released March 6 show Bausch & Lomb's sales declined 3% to $2.29 billion in 2006 primarily because lens care sales were down 21% for the year to $414.2 million. The firm estimates its share of the U.S. multipurpose solutions market dropped from 30% in 2005 to 18% at the end of 2006 because of a recall of ReNu with MoistureLoc (1"The Gray Sheet" Nov. 13, 2006, p. 18). Bausch & Lomb expects to officially file its 2006 report by April 30. Also March 6, Bausch & Lomb voluntarily recalled 12 lots of ReNuMultiPlus lens care solution, citing an elevated level of trace iron that may indicate a shortened shelf life for the product. The firm does not expect the latest recall to have a significant financial impact...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel